课题基金 / 基金详情

Molecular mechanisms of Insulin signal transduction and diabetes mellitus

Molecular mechanisms of Insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
批准号:
20390095
负责人:
EBINA Yousuke
金额:
$12.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

EBINA Yousuke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Akt substrate of 160kDa (AS160) is a Rab GTPase activating protein (GAP) and was recently identified as a component of the insulin signaling pathway of glucose transporter type 4 (GLUT4) translocation. We and others, previously reported that the activation of Galphaq protein-coupled receptors (GalphaqPCRs) also stimulated GLUT4 translocation and glucose uptake in several cell lines. Here, we report that the activation of GalphaqPCRs also promoted phosphorylation of AS160 by the 5'-AMP activated proteinkinase (AMPK). Rat 3Y1 cells lacking AS160 did not show insulin-induced GLUT4 translocation. The cells stably expressing GLUT4 revealed GLUT4 vesicles that were mainly localized in the perinuclear region and less frequently on the cell surface. After expression of exogenous AS160, GLUT4 on the cell surface decreased and GLUT4 vesicles were redistributed throughout the cytoplasm. Although PMA-induced or sodium fluoride-induced GLUT4 translocation was significantly increased in these cells, insulin did not affect GLUT4 translocation. These results suggest that AS160 is a common regulator of insulin-and GalphaqPCR activation-mediated GLUT4 distribution in the cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel ultra-sensitive enzyme immunoassay for soluble human insulin receptor ectodomain and its measurement in urine from healthy subjects and patients with diabetes mellitus
一种新型超灵敏酶联免疫分析方法,用于检测可溶性人胰岛素受体胞外域及其在健康受试者和糖尿病患者尿液中的测量
DOI: --
发表时间: 2009
期刊: Clinical Biochemistry 42(13-14)
影响因子: --
作者: [Mori T, Nagamura-Inoue T, et al., Umehara A.]
通讯作者: Umehara A.
Soluble insulin receptor ectodomain level was elevated in the plasma of cancer patients
癌症患者血浆中可溶性胰岛素受体胞外域水平升高
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Yuasa T. et., al.]
通讯作者: al.
可溶化インスリン受容体細胞外ドメイン(sIR)は癌患者血清中で増加している
癌症患者血清中可溶性胰岛素受体胞外结构域 (sIR) 增加
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [湯浅智之, 小畑利之, 矢野聖二, 岡本英治, 西岡安彦, 久保宜明, 高橋正幸, 中逵弘能, 長屋寿雄, 金山博臣, 荒瀬誠治, 曽根三郎, 蛯名洋介]
通讯作者: 蛯名洋介
Soluble insulin receptor ectodomain in the plasma is a possible broad-spectrum tumor marker
血浆中的可溶性胰岛素受体胞外域是一种可能的广谱肿瘤标志物
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Yuasa T. et., al.]
通讯作者: al.
13
    Is insulin inactivated by the binding with serum soluble insulin receptor(sIR)?
    • 批准号:
      23659156
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      EBINA Yousuke
    • 依托单位:
    Molecular mechanisms of insulin signal transduction and diabetes mellitus
    • 批准号:
      18390104
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.77万
    • 财政年份:
      2006
    • 负责人:
      EBINA Yousuke
    • 依托单位:
    Molecular mechanisms of insulin signal transduction and diabetes mellitus
    • 批准号:
      16390097
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2004
    • 负责人:
      EBINA Yousuke
    • 依托单位:
    Molecular mechanisms of insulin signal transduction and diabetes mellitus
    • 批准号:
      14370045
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2002
    • 负责人:
      EBINA Yousuke
    • 依托单位:
    海外基金